We are live on ! Find out more
TE

Tema ETFs Portfolio holdings

AUM $3.09B
1-Year Est. Return 72.72%
This Fund
S&P 500
This Quarter Est. Return
+13.47%
1 Year Est. Return
+72.72%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$377M
AUM Growth
+$41.9M
Cap. Flow
+$7.27M
Cap. Flow %
1.93%
Top 10 Hldgs %
20.9%
Holding
176
New
29
Increased
67
Reduced
61
Closed
11

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$8.67M
2
CGNX icon
Cognex
CGNX
+$6.97M
3
CRH icon
CRH
CRH
+$5.6M
4
LIN icon
Linde
LIN
+$5.07M
5
JCI icon
Johnson Controls International
JCI
+$3.32M

Top Sells

Rank Stock Value
1
VMC icon
Vulcan Materials
VMC
+$5.18M
2
ROK icon
Rockwell Automation
ROK
+$4.19M
3
APG icon
APi Group
APG
+$4.13M
4
CLH icon
Clean Harbors
CLH
+$4.11M
5
WCC
WESCO International
WCC
+$3.88M

Sector Composition

Rank Sector Weight
1 Industrials 38.16%
2 Healthcare 30.66%
3 Technology 10.25%
4 Utilities 8.88%
5 Materials 5.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIIB icon
151
Biogen
BIIB
$30.4B
$315K 0.08%
2,511
+10
+0.4% +$1.25K
MREO
152
Mereo BioPharma
MREO
$49.5M
$278K 0.07%
102,583
-552,083
-84% -$1.33M
AUTL
153
Autolus Therapeutics
AUTL
$383M
$274K 0.07%
120,388
+9,960
+9% +$16.5K
NUVB icon
154
Nuvation Bio
NUVB
$2.02B
$272K 0.07%
+139,648
New +$291K
ANAB icon
155
AnaptysBio
ANAB
$1.72B
$253K 0.07%
+11,404
New +$239K
CPRX
156
DELISTED
Catalyst Pharmaceutical
CPRX
$246K 0.07%
11,352
– –
AXSM icon
157
Axsome Therapeutics
AXSM
$11.8B
$243K 0.06%
2,327
– –
RACE icon
158
Ferrari
RACE
$66.3B
$230K 0.06%
+469
New +$218K
ACAD icon
159
Acadia Pharmaceuticals
ACAD
$4.38B
$229K 0.06%
10,596
– –
CELC icon
160
Celcuity
CELC
$4.31B
$227K 0.06%
17,011
+1,392
+9% +$15.2K
NTLA icon
161
Intellia Therapeutics
NTLA
$1.59B
$226K 0.06%
24,053
-2,484
-9% -$20.4K
DNLI icon
162
Denali Therapeutics
DNLI
$3.7B
$212K 0.06%
15,174
– –
RCKT icon
163
Rocket Pharmaceuticals
RCKT
$376M
$78.5K 0.02%
32,030
-4,833
-13% -$24.5K
TALK icon
164
Talkspace
TALK
$873M
$77.4K 0.02%
27,834
– –
VYGR icon
165
Voyager Therapeutics
VYGR
$192M
$46.5K 0.01%
14,960
– –
ADI icon
166
Analog Devices
ADI
$183B
– –
-4,664
Closed -$941K
BPMC
167
DELISTED
Blueprint Medicines
BPMC
– –
-20,972
Closed -$1.86M
DCI icon
168
Donaldson
DCI
$10.5B
– –
-11,848
Closed -$795K
INCY icon
169
Incyte
INCY
$23.4B
– –
-5,042
Closed -$305K
LNTH icon
170
Lantheus
LNTH
$7B
– –
-4,329
Closed -$423K
ORIC icon
171
Oric Pharmaceuticals
ORIC
$1.11B
– –
-40,934
Closed -$228K
TECH icon
172
Bio-Techne
TECH
$11.2B
– –
-11,252
Closed -$660K
TER icon
173
Teradyne
TER
$50.5B
– –
-13,611
Closed -$1.12M
WCC
174
WESCO International
WCC
$16B
– –
-24,991
Closed -$3.88M
XENE icon
175
Xenon Pharmaceuticals
XENE
$6.6B
– –
-6,111
Closed -$205K
4 5 6
7
8

Similar funds

DCM
Donaldson Capital Management Evansville, Indiana $3.09B AUM 21.24% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.11B AUM 20.67% 1-Year Est. Return
TCG
Tremblant Capital Group West Palm Beach, Florida $3.11B AUM 18.12% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
CAM
Contour Asset Management New York $3.08B AUM 21.94% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
FI
Focused Investors Los Angeles, California $3.08B AUM 12.02% 1-Year Est. Return

Tema ETFs's Q2 2025 Portfolio in Review

As of Q2 2025, Tema ETFs held 176 positions worth $377M, up 13% from $335M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Tema ETFs's Q2 2025 filing shows 29 new, 67 increased, 61 reduced and 11 closed positions. Its largest new stake was Eaton: 28,145 shares worth $10M. The largest sale was Vulcan Materials, an estimated $5.18M.

By sector, the portfolio is most concentrated in Industrials at 38% of assets, down from 43% a quarter earlier, followed by Healthcare and Technology.

  • Tema ETFs's largest Q2 2025 buy was Eaton: 28,145 shares worth $10M.
  • Tema ETFs added most to Entergy in Q2 2025, an estimated $1.59M increase.
  • Tema ETFs's biggest Q2 2025 reduction was Vulcan Materials, cutting an estimated $5.18M.
  • Tema ETFs fully exited WESCO International in Q2 2025, selling an estimated $3.88M.
  • Tema ETFs's ten largest holdings make up 21% of its $377M portfolio in Q2 2025.
  • Tema ETFs opened 29 new positions and closed 11 in Q2 2025.
  • Tema ETFs's portfolio value rose 13% quarter-over-quarter to $377M.

Based on Tema ETFs's 13F filing for Q2 2025, filed 13 Aug 2025.